Key Highlights
- Shares of Lam Research (LRCX) reached a record peak of $274.42, posting a remarkable 262% gain over 12 months
- Third-quarter fiscal results surpassed analyst projections; fourth-quarter outlook exceeded market expectations
- TD Cowen increased its price objective to $340 from $290, reaffirming its Buy recommendation
- Multiple Wall Street firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain bullish stances
- Management disclosed the firm has already achieved its 2028 financial targets ahead of schedule
Shares of Lam Research (LRCX) surged to a fresh all-time peak of $274.42 during Thursday’s trading session, marking the culmination of an extraordinary 12-month rally that saw the stock appreciate over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro reveals the semiconductor equipment manufacturer delivered a one-year return of 267%, with shares currently trading within 1% of their 52-week pinnacle of $273.50.
The remarkable upward trajectory has been fueled by robust financial performance and a wave of optimistic analyst revisions in recent weeks.
Lam delivered fiscal third-quarter financial results that exceeded both Stifel’s projections and broader Wall Street consensus. Additionally, the company provided fourth-quarter guidance that topped expectations across both revenue expansion and profit margin metrics.
Executive leadership highlighted that the organization has already achieved its target financial framework for calendar year 2028 and the period beyond — marking an ahead-of-schedule milestone.
Wall Street Analysts Elevate Price Objectives
TD Cowen analyst Krish Sankar boosted his price objective for LRCX to $340 from $290 this Wednesday, maintaining his Buy recommendation. While Sankar recognized that skeptics may highlight limited upside potential following the robust June quarter guidance and premium valuation multiples, he contended that client demand strength and profitability trends warrant additional upward estimate revisions.
Stifel similarly preserved its Buy rating while elevating its price target to $325, emphasizing the impressive quarterly performance.
RBC Capital upgraded its target to $310, highlighting robust demand stemming from generative AI applications and competitive market share expansion, alongside an enhanced projection for wafer fabrication equipment expenditures in 2026.
Cantor Fitzgerald maintained its Overweight stance with a $320 price objective, referencing an improved wafer fabrication equipment landscape extending through 2026 and 2027.
UBS confirmed its Buy rating, emphasizing Lam’s evolution into what analysts characterized as an AI-powered expansion phase.
Strong Financial Metrics Support Rally
Lam’s underlying financial health has remained solid throughout the stock’s appreciation. The semiconductor equipment provider boasts a flawless Piotroski Score of 9, indicating exceptional financial stability, while 20 analysts have recently upgraded their earnings projections, per InvestingPro data.
TD Cowen’s Sankar acknowledged that bearish investors will point to elevated multiples following the strong guidance, but the firm maintains that customer demand dynamics and profitability levels continue to provide support.
LRCX concluded Thursday’s session approximately 4% higher, with shares positioned near their newly established all-time record of $274.42.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
